evidence: AR rates in True, Sham, and Control were 40.0%, 9.1%, 18.2%, respectively, yet statistically no significant difference was seen between the three arms (Fig. 3).
intervention: Weekly granulocyte/monocyte adsorption (GMA)
comparator: no additional intervention
outcome: non-relapsing ratio (% avoiding relapse [AR]) over week 48